March 9, 2026 - 12:58

An Iranian-made drone used in an attack on a Royal Air Force base in Cyprus earlier this month incorporated Russian technology, according to a new report. The one-way attack drone struck the Akrotiri airbase on March 1, causing minor damage but no injuries.
The incident marks a significant escalation, representing the first time Iranian forces have directly targeted a British military facility. Analysis of the drone's debris revealed key components that were manufactured in Russia. This finding underscores the deepening military cooperation between Tehran and Moscow and raises serious concerns about the proliferation of advanced drone technology in the region.
Security officials are investigating how the drone evaded detection before impacting the base, which is a critical operational hub for missions in the Middle East. The attack has prompted urgent reviews of air defense systems and force protection measures across British installations in the Eastern Mediterranean. The use of Russian parts in the weapon highlights the interconnected nature of modern conflict and the challenges faced by Western powers in countering hybrid threats.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...